Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 129 Colonic Neoplasms 54 Rectal Neoplasms 48 Carcinoma, Hepatocellular 29 Stomach Neoplasms 23 Neoplasm Metastasis 23 Neoplasms 11 Pancreatic Neoplasms 10 Cholangiocarcinoma 9 Adenocarcinoma Of Esophagus 8 Esophageal Neoplasms 7 Liver Neoplasms 6 Gastrointestinal Neoplasms 5 Biliary Tract Neoplasms 5 Recurrence 4 Ovarian Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 3 Digestive System Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Unresectable Metastatic Colorectal Cancer 2 Peritoneal Neoplasms 2 Neurotoxicity Syndromes 2 Neoplastic Cells, Circulating 2 Intestinal Neoplasms 2 Gastrointestinal Diseases 2 Gallbladder Neoplasms 2 Colorectal Cancer Metastatic 2 Cirrhosis, Familial, with Pulmonary Hypertension 2

Interventions

Cyclophosphamide 23 blinatumomab 18 Cytarabine 16 fludarabine 13 Azacitidine 12 venetoclax 10 fludarabine phosphate 10 Rituximab 8 Blood Specimen Collection 8 Methotrexate 7 Lenalidomide 7 Dexamethasone 7 Daunorubicin 7 Mercaptopurine 6 Vincristine 5 daratumumab 4 Whole-Body Irradiation 4 Melphalan 4 Idarubicin 4 Etoposide 4 Drug Therapy 4 Busulfan 4 pembrolizumab 3 obinutuzumab 3 Radiotherapy 3 Neoadjuvant Therapy 3 Maintenance 3 Liquid Biopsy 3 Immunotherapy, Adoptive 3 Imatinib Mesylate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Folfox protocol × Clear all

NCT05534087 2024-11-29

CLAUDIA

Seoul National University Hospital

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡